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The St. Jude valve is a new bileaflet disc cardiac valve
prosthesis designed to avoid some of the hemodynamic
drawbacks of other prostheses. The in vivo flow char-
acteristics of the St. Jude aortic valve (42 patients) were
studied and compared with those of three other com-
monly used aortic prostheses. Bjork-Shiley (12 patients),
Hancock (27 patients) and Carpentier-Edwards (15 pa-
tients). The studies, performed 24 to 48 hours after sur-
gery, included measurements at rest and during aug-
mentation of valve flow by infusion of isoproterenol.
The mean performance index for valves of all sizes
is higher for the St. Jude than for either porcine valve,
both at rest and during isoproterenol infusion (p < 0.05).
Utilizing data both at rest and with isoproterenol, the
relation of valve flow and mean systolic gradient for each
size of St. Jude valve (19 to 25 mm) indicates the oc-
currence of small increases in gradient (5.3 to 8.2 mm
Hg) as valve flow increases, ranging from 161 to 436
ml/systolic·min. A direct comparison of valve flow and
gradient data for all size 25 and 23 mm prostheses at
rest indicates a tendency for a lower mean systolic gra-
dient in both mechanical valves than in either porcine
valve (p = 0.07). With isoproterenol augmentation of
In contrast to the normally functioning human valve, all
cardiac valve substitutes represent a compromise in some
manner. Recognition of this fact has led to a number of
modifications and model changes and the development of
new prosthetic types. For instance, excellent durability has
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valve flow in 25 mm valves, the gradient is less (p <
0.05), and the effective orifice area and performance
index are larger (p < 0.05) for the St. Jude than for
either porcine valve. The performance of the 25 mm
Bjork-Shiley valve follows a trend similar to that of the
St. Jude valve, but does not reach statistical significance
because fewer valves of this type were available for test-
ing. In size 23 valves with isoproterenol, only the St.
Jude valve has a lower gradient, larger effective orifice
area and performance index than the Carpentier-Ed-
wards valve, there being too few Bjork-Shiley and Han-
cock valves in this category to provide a comprehensive
analysis.
Thus, hydrodynamic function of the St. Jude pros-
thesis is similar to that of the Bjork-Shiley valve for flow
rates at rest. At a higher valve flow (with isoproterenol),
in size 25 mm valves, function of both mechanical
prostheses is superior to that of both porcine valves; in
size 23 mm, our data suggest that function of the St.
Jude valve may also be superior to that of the Bjork-
Shiley valve. However, this comparison is limited by the
small number of Bjork-Shiley prostheses tested with
isoproterenol.
been achieved with the highly successful caged-ball valves
(1-3), yet reports indicate that hemodynamic performance
may not be ideal (4-7) and that thromboembolism, throm-
bosis and hemolysis have continued to be problem areas
(3,5,6,8-15).
Significant developments of the past decade have in-
cluded the introduction of two unique valve types, each to
deal with a special problem associated with the prosthetic
valve recipient. Glutaraldehyde-fixed porcine tissue valves
were designed to lessen the incidence of thrombosis and
thromboembolic complications (16,17), and tilting disc valves
to improve hemodynamic performance (18-20). Because
valve replacement is performed to relieve a hemodynamic
burden, its ultimate success must depend at least in part on
the degree to which that end is achieved and on the nature
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of any sacrifice to prosthetic durability and thrombotic po-
tential incurred.
The St. Jude bileafletprosthesis is one of the latestentries
into the category of mechanical valves. Our interest in the
use of this device began in 1978 after very encouraging in
vitro hemodynamic results were reported (21). On the basis
of our clinical experience (22,23) and preliminary hemo-
dynamic data (24), continued use seems warranted. How-
ever, more comprehensive hydrodynamic data are lacking,
especially those comparing it withotherwidely usedprostheses
of contemporary design.
This study was designed to compare the in vitro (reported
elsewhere in this issue [25]) and in vivo flow characteristics
of St. Jude, Bjork-Shiley, Hancockand Carpentier-Edwards
aortic valves of various commonly used sizes. This in vivo
study was particularly designed to focus on valves that,
becauseof their brief periodof implantation and the patient's
excellent postoperative course, are believed to be function-
ing normally. Thus, we are able to study and compare the
intrinsicfunctionof each prosthesis in its optimal state with-
out added influences such as thrombus or fibrin deposition.
In many instances, the studies were performed both at rest
and under conditions of simulated exercise with isoproter-
enol infusion.
Methods
gradient. It was given in a concentration of 8 fLg/ml; the end
point of titration was a heart rate of approximately 120
beats/min. No seriousuntowardreactionwasobservedusing
this protocol, although single ventricularextrasystoles were
occasionally seen and a minor degree of restlessness was
noted in 10% of patients.
Data analysis. Pressure tracings were digitized using a
hand-held cursor and special computer program to provide
automated planimetry of the pressure gradients. Formulas
forcalculation of various valve function indexes areas follows:
Flow. Cardiac output (CO) was used to calculate systolic
valve flow (Q) using the formula:
CO
Q = SEP x HR'
where SEP = systolicejection period and HR = heart rate.
Discharge coefficient. The discharge coefficient (Cd) is
a measure of how effectively a valve uses its primary flow
area. It is calculated from the formula:
EOACd =--
AOA'
where EOA = effective orifice area (crrr') and AOA
actual orifice area (crrr').
Effective orifice area. Effective orifice area (EOA) is
calculated from:
EOA
PI =-SRA'
Performance index. Performance index (PI) is a measure
of how effectively a valve uses the tissue anulus area. It is
calculated from the formula:
Q
EOA
Cd x 44.6 x VIP'
where Cd is arbitrarily assigned a value of I; 44.6 = grav-
itational acceleration constant and A f> = valve pressure
gradient.
where SRA = sewing ring area (ern").
Statistical analysis. All sizes of each valve type were
combined and the gradient, flow, orifice area and perform-
ance index of the four groups were compared using an
analysis of variance model. This was repeated using valve
sizes 23 and 25 only. A parametric analysis was used when
distributions of the variables were normal and variances in
the four valve groups were equivalent. The Kruskal-Wallis
nonparametric analysisof variancewas usedwhen variances
differed significantly between valve groups (as determined
by Levene's test), or when the data withina valve type were
scant. When the analysis of variance yielded a p value less
than 0.05, specific differences between valve groups were
Patients. Ninety-six aortic valve recipients, ranging in
age from 26 to 81 years (61 ± II, mean ± standard de-
viation) were studied. There were 42 St. Jude, 12 Bjork-
Shiley, 27 Hancock and 15 Carpentier-Edwards prostheses.
Additional replacement of the mitral valve was performed
in 31 patients.
Procedure. The distribution of valve sizes parallels our
clinical choice of valve substitutes. A mechanical prosthesis
is frequently chosen for patients with a small aortic anulus
(:5 23 mm), typically a patient with aortic stenosis. Con-
versely, patients with a larger anulus would be likely to
receive a porcine valve of larger size.
Transvalvular gradients were measured by means of a
surgically placed direct left ventricular 18 gauge polyvinyl
catheter and an 18 gauge radial artery catheter connected
by equal lengths of identical pressure tubing to identically
calibrated separate pressure transducers (Honeywell model
4-327-1). All pressures were recorded simultaneously with
an Electronics for Medicine VR-6 recorder using light-sen-
sitive paper. Although transducer drift was negligible, re-
checking of calibration accuracy was performed every 15
minutes. At the time of each recording, thermodilution car-
diac output was measured in duplicate. All studies were
performed between 24 and 48 hours after surgery.
Intravenous isoproterenol infusion was used to simulate
exerciseand thus promote developmentof any transvalvular
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investigated using either the Newman-Keuls test (for par-
ametricanalysisof variance)or the Fisher's least significant
differences test (for nonparametric analysis of variance),
The linear relation between systolic gradient and valve flow
for each of the four sizes of St. Jude valves was assessed
using a linear regression model.
Results
Table I shows the data for all valves studied, grouped
by size (19 through 29 mm) and by manufacturer. Table 2
shows the response to isoproterenol infusion.
The calculated performance index reflects the efficiency
of prosthetic design and is less subject to changes in valve
size. It is therefore quite useful to view such data in groups
of patientswith variouslysized valvesof a similar type (26),
This information is found in the column at the far right in
Tables I and 2, Both at control and with isoproterenol in-
fusion, the performance index is greater with the St. Jude
valve than with either porcine valve (p < 0.05), At control,
performance index for the Bjork-Shiley valve is larger than
for the Carpentier-Edwards valve; with isoproterenol it is
greater for the Bjork-Shiley valve than for both porcine
valves (p < 0,05). No significant differencesin performance
index exist between the two mechanical or two porcine
prostheses either at control or with infusionof isoproterenol.
St. Jude gradient/flow data. Figure I shows the indi-
vidualdata for all four sizesof St. Jude valvetested, utilizing
Table 1. Control Measurements
both control and isoproterenol responses. The valves are
grouped by size (25 to 19 mm). The figure shows how the
transvalvular pressure gradient changes with alteration of
systolic flow in valves of various sizes.
A linear regression model was used to construct a regres-
sion line through each set of points. Although using two
measurements (control and isoproterenol) on each patient
precludes statistical comparisons of the obtained regression
lines, the lines provide descriptive evidence that the flow-
gradient relation is affected by valve size. Displacement of
the curve downward and to the right indicates less increase
in pressure gradientas systolicflow increases, meaningthere
is more efficient utilization of the primary flow orifice. Al-
though, as expected, there is a tendency of the curves to
assume a more upright position (higher pressure gradient
for any given flow) in smaller valve sizes, this tendency is
small, and no dramatic elevation in pressure gradient is
noted even in small valves (19 and 21 mm) with systolic
flow of up to 400 ml/systolic- second. For purposesof com-
parison, all four regression lines are superimposed and il-
lustrated in Figure 2,
Comparison of 23 and 25 mm valve performance at
rest. Because the distribution of valve sizes in our study
favors mechanical prostheses in the smaller sizes (St. Jude,
Bjork-Shiley) and porcine valves in the larger sizes (Han-
cock, Carpentier-Edwards), a direct comparison of hemo-
dynamic data for all prostheses in all sizes is not possible.
In size 25 and 23 mm valves, however, there is enough
overlap for such a comparison. Again the data are repre-
Valve Size (mm)
Valve
SI. Jude
Gradient (mm Hg)
Flow (ml/systolic . min)
EGA (cm/)
PI
Bjork-Shiley
Gradient (mm Hg)
Flow (ml/systolic . min)
EGA (crrr')
PI
Carpentier-Edwards
Gradient (mm Hg)
Flow (ml/systolic . min)
EGA (crrr')
PI
Hancock
Gradient (mm Hgj
Flow (ml/systolic . min)
EGA (crrr')
PI
19
n = 3
7.2 ± 4.5
161 ± 28
1.58 ± 0.69
0.56 ± 0.24
21
n = 17
5.8 ± 4.9
198 ± 43
2.42 ± 1.32
0.70 ± (U8
n = 2
3.5 ± 1.7
232 ± 72
3.03 ± 1.64
0.88 ± 0.47
23
n= 16
5.4 ± 5.3
238 ± 57
3.18 ± 1.59
0.76 ± 0.38
n = 5
6.3 ± 2.9
223 ± 50
2.07 ± 0.45
0.50 ± 0.11
n = 6
10.7 ± 5.7
214 ± 48
1.69 ± 0.81
0.41 ± 0.20
25
n = 6
3.5 ± 1.6
249 ± 96
3.28 ± 1.53
0.67 ± 031
n = 3
4.9 ± 3.9
307 ± 165
3.51 ± 1.66
0.72 ± 0.34
n = 9
9.6 ± 7.1
272 ± 75
2.53 ± 1.39
0.52 ± 0.28
n = 10
7.9 ± 4.1
262 ± 73
2.23 ± 0.74
0.46 ± 0.15
27
n = 2
2.2 ± 1.6
216 ± 54
3.57 ± 0.61
0.62 ± 0.11
n = 12
8.4 ± 9.1
288 ± 67
2.81 ± 1.48
0.49 ± 0.26
29
n = 5
5.5 ± 2.6
324 ± 53
3.33 ± 0.77
0.50 ± 0.12
Mean
Values
n = 42
0.67 ± 0.33
n = 12
0.68 ± 0.26
n = 15
0.47 ± 0.22
n = 27
0.48 ± 0.18
EGA = effective orifice area; PI = performance index. Values are mean ± standard deviation.
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Table 2. Response to Isoproterenol Infusion
Valve Size (mm)
Mean
Valve 19 21 23 25 27 29 Values
St. Jude n = 3 n = 16 n = 13 n = 4 n = 36
Gradient (mm Hg) 15.1 ± 2.6 14 ± 7.6 12.4 ± 6.8 8.7 ± 8.4
Flow (ml/systolie . min) 246 ± 54 286 ± 64 321 ± 73 436 ± 241
EGA (crrr') 1.44 ± 0.41 1.98 ± 0.94 2.46 ± 1.26 4.43 ± 2.6
PI 0.51 ± 0.15 0.57 ± 0.27 0.50 ± 0.30 0.90 ± 0.53 0.62 ± 0.52
Bjork-Shiley n = 2 n = 2 n = I n = 5
Gradient (mm Hg) 13.6 ± 13.3 8.4 ± 1.9 13.7
Flow (mllsystolie . min) 278 ± 120 411 ± 82 488
EGA (crrr') 1.91 ± 0.30 3.26 ± 1.00 2.97
PI 0.46 ± 0.07 0.66 ± 0.21 0.52 0.55 ± 0.14
Carpentier-Edwards n = 5 n = 7 n = 12
Gradient (mm Hg) 27.8 ± 13.6 24.4 ± 8.2
Flow (mllsystolie . min) 281 ± 73 396 ± 62
EGA (em 2) 1.26 ± 0.42 1.84 ± 0.24
PI 0.30 ± 0.10 0.37 ± 0.05 0.34 ± 0.8
Hancock n = 8 n = 10 n = 3 n = 21
Gradient (mm Hg) 21.4 ± 9.7 15.9 ± 5.4 10.8 ± 6.2
Flow (mllsystolie . min) 402 ± 91 424 ± 55 480 ± 48
EGA (ern") 2.05 ± 0.51 2.50 ± 0.60 2.53 ± 0.22
PI 0.42 ± 0.10 0.44 ± 0.10 0.38 ± 0.03 0.41 ± 0.08
Values are mean ± standard deviation. Abbreviations as in Table 1.
sented by regression lines derived from the raw data. Figure
3A shows the comparison of transvalvular pressure gradient
and resting systolic flow for 25 mm St. Jude, Carpentier-
Edwards, Hancock and Bjork-Shiley valves. In size 25 mm
valves, the St. Jude and Bjork-Shiley valves have a lower
pressure gradient for a given flow than Carpentier-Edwards
and Hancock valves. The size 23 mm St. Jude valves (Fig.
38) have a lower pressure-flow curve than that of Carpen-
tier-Edwards valves of equal size; at this smaller size, the
St. Jude valve also appears to have a lower pressure gradient
for a given flow than does the Bjork-Shiley valve (Fig. 3B).
Comparison of isoproterenol response in 23 and 25
mm valves. Figure 4 shows the effect of isoproterenol
administration on mean pressure gradient and flow values
in each valve group. In the 25 mm size, both mechanical
prostheses have less increase in pressure gradient with the
infusion of isoproterenol than does either porcine valve. In
size 23 mm valves, the pressure gradient increase is less
with the St. Jude and Bjork-Shiley valves than with the
Carpentier-Edwards valves, only two Bjork-Shiley valves
of this size were tested with isoproterenol (Fig. 48).
In sizes 25 and 23 mrn, both the St. Jude and Bjork-
Shiley valves have a lower pressure gradient and a higher
effective orifice area than either porcine valve (p < 0.05).
Of the 23 mm prostheses, the St. Jude has a lower pressure
gradient and higher effective orifice area than the remaining
porcine valve (Carpentier-Edwards) (p < 0.05). The same
is true for the performance index; that is, in 25 mm valves
the mean performance index is higher for the St. Jude valve
than for either porcine valve (p < 0.05); that of the Bjork-
Shiley valve is higher only than that of the Carpentier-
Edwards valve (p < 0.05) which is, in turn, higher than
that of the Hancock valve (p < 0.05). In the smaller 23
mm size, only the St. Jude valve has a performance index
larger than that of the porcine valves (p < 0.05), owing in
part to the small number of Bjork-Shiley valves studied in
this category.
Discharge coefficient. Becauseof disagreement about the
accuracy of available data on actual orifice area of porcine
valves, we have not reported the discharge coefficient for
these prostheses (which requires actual orifice area for its
calculation). For the St. Jude prosthesis, the values for dis-
charge coefficient at control and with isoproterenol are shown
in Table 3. The mean values for each size of St. Jude valve
are close to 1.00, indicating that the (calculated) effective
orifice area is very nearly the same as the actual (measured)
orifice area. An interesting trend, noted in all sizes, is the
tendency for the discharge coefficient to be smaller with the
infusion of isoproterenol. This suggests that under condi-
tions of higher flow, turbulence may occur, and the resulting
power loss is expressed as a less efficient use of the primary
orifice area.
Discussion
This analysis of in vivo prosthetic valve performance
encompasses the spectrum of typical aortic prosthesis sizes
and types commonly used at our institution. We used para-
meters and methods of calculation similar to those used for
JACCVol. 3. No.2
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fibrin deposition and tissue infiltration, such an analysis was
not the intent of our investigation. Furthermore, the ability
to perform late postoperative hemodynamic studies in such
patients is limited by the risk of catheterization, particularly
in aortic valve recipients. At present, no generalizations
about the clinical relevance of our findings are warranted.
The importanceof our data to the individual patient depends
on the state of preoperative ventricular function and the
degree to which any residual hemodynamic burden may be
tolerated.
We found that both mechanical prostheses have effec-
tively relieved the patient of any significant systolic me-
chanical burden. The porcine valves have acceptable per-
formance except under conditions of hemodynamic stress
inducedby isoproterenol, at whichtimethey begin to produce
some resistance to left ventricular outflow. In the smallest
size valves (19 and 21 mm) no direct comparison is possible,
but in the 23 mm size, the St. Jude valve does retain efficient
function. At size 25 mm, no difference in mechanical
prostheses are discernible.
Possible limitations. The use of radial artery pressure
for gradient measurements is a possible weakness of our
Figure 2. Valve pressure gradient and flow relation. Regression
lines for 25.23.21 and 19 mm St. Jude valves are superimposed
for comparison.
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Figure l. Valve pressure gradient and systolic flow relation in
St. Jude valves. sizes 25 through 19 mm (A to D). The individual
data points are described by the regression line.
comprehensive in vitro studies of mitral prostheses previ-
ously reported by Gabbay et al. (26,27).
The study was intentionallydesigned to analyze and com-
pare prosthetic mechanical function in valves that are func-
tioning normally, consistent with the design features of each.
Although long-term or later studies of prosthetic function
may be useful in determining the potential effects of such
factors as tissue ingrowth (pannus), thrombus formation,
Table 3. Measurements of Discharge Coefficient
SI. Jude Valve Size Control Isoproterenol
19 mm 0.97 ± 0.42 0.88 ± 0.25
(n = 3) (n = 3)
21 mm 1.18 ± 0.64 0.96 ± 0.46
(n = 17) (n = 16)
23 mm 1.25 ± 0.62 0.96 ± 0.50
(n = 14) (n = 13)
25 mm 1.06 ± 0.31 1.43 ± 0.85
(n = 6) (n = 4)
Mean 1.12 ± 0.50 1.06 ± 0.52
Values are mean ± standard deviation.
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Figure 4. Valve pressure gradient and systolic flow relation at
control and after isoproterenol infusion. Mean data for sizes 25
mm (A) and 23 mm (8) are shown for St. Jude, Bjork-Shiley,
Hancock and Carpentier-Edwards valves.
erative left ventricular function). It would be an additional
alternative for patients not considered to be a good recipient
for a porcine valve, such as those of the pediatric or young
adult age group as well as patients with altered calcium
metabolism.
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Figure 3. Valve pressure gradient and systolic flow relations at
rest in 25 mm (A) and 23 mm (8) St. Jude, Bjork-Shiley, Hancock
and Carpentier-Edwards valves. The data are represented by the
individual regression lines.
methodology. This becomes less important because all mea-
surements are expressed as mean (determined by planime-
try) systolic gradient; no peak gradients were reported. Fur-
thermore, all patients were studied using an identical
methodology so that any remaining possibility for error would
be spread evenly across all groups of patients and valve
types.
Implications. We believe that our initial impression of
the performance of the St. Jude valve (23) is supported in
this evaluation. Compared with the other standard and widely
used prostheses tested, we believe the St. Jude valve is
particularly suited for patients with a small aortic anulus (s
25 mm) and for any patient less likely to tolerate a residual
systolic pressure gradient (that is, those with poor preop-
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